Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have signed the consent form agreeing to participate.
- You are 18 years old or older (any gender can apply).
- You are able to carry out daily activities with little to no limitation, as measured by a standard health scale (confirm with trial site).
- Your doctor estimates you have a life expectancy of at least 3 months.
- You have been diagnosed with an advanced solid tumour (confirmed by a lab test) that has stopped responding to standard treatments, that you could not tolerate, or for which no standard treatment exists.
- You have at least one tumour that can be measured on a scan, or at least one affected bone lesion.
- Your bone marrow, liver, kidneys, and other organs are functioning well enough to participate (confirm with trial site).
Who may not be able to join:
- You have been diagnosed with two or more separate cancers in the past 5 years.
- You have received chemotherapy in the last 3 weeks, or radiation, biological, hormonal, or immunotherapy treatment in the last 4 weeks.
- You have taken part in another trial using an unapproved drug or therapy in the last 4 weeks.
- You have cancer that has spread to the brain, bone marrow, the lining of the brain or spinal cord, the brainstem, or is pressing on the spinal cord.
- You have severe bone damage caused by prostate cancer that has spread to the bones.
- You still have side effects from previous cancer treatment that have not cleared up sufficiently (confirm with trial site).
- You have a serious lung condition that affects your breathing or lung function.
- You have received a vaccine within the last 4 weeks before starting the trial.
- You have an active infection requiring treatment within the last 7 days.
- You have serious heart or stroke-related conditions.
- You have a significant build-up of fluid in body cavities (such as the abdomen or chest) that cannot be managed (confirm with trial site).
- You have had significant bleeding, a known tendency to bleed, or wounds that are not healing within the past month.
- You are known to be allergic to the trial drug or any of its ingredients.
- You have a substance use issue or a mental health condition that may affect your ability to take part in the study.
- You are known to be dependent on alcohol or drugs.
- You are pregnant, breastfeeding, or planning to become pregnant.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 86 0571-86963293
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
(Dose-Escalation Stage): Dose-Limiting Toxicity (DLT) and Maximum tolerated dose (MTD) for MHB048C; (Dose-Expansion Stage): Objective tumor response (ORR) determined by investigators according to RECIST v1.1
Can't join this trial?
Data last synced from ClinicalTrials.gov: 5 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.